AKA email 11/28 Scientists Question FDA 8 Factor Analysis
-
bubbles
- Super Kratomite (Rank 3)
- Posts: 84
- Joined: Fri Apr 06, 2018 12:56 am
AKA email 11/28 Scientists Question FDA 8 Factor Analysis
Hi guys! Hope everyone is well. AKA just sent this out.
LEADING SCIENTISTS RELEASE LETTER CRITICAL OF FDA'S 8-FACTOR ANALYIS
LEADING SCIENTISTS STRONGLY REJECT FDA'S 8-FACTOR ANALYSIS OF KRATOM
CALL UPON THE DEA AND NIDA TO RE-EXAMINE KRATOM ANALYSIS
Washington, D.C.
November 28, 2018
Leading scientists have made public a 33-page letter they have sent to the heads of the U.S. Department of Health and Human Services (HHS), the U.S. Food and Drug Administration (FDA), the Drug Enforcement Administration (DEA), and the National Institute on Drug Abuse (NIDA) expressing strong objections to the methodology and lack of scientific rigor of the FDA's 8-Factor Analysis (8 FA) of kratom.
Among multiple questions raised by the scientists—led by Dr. Jack Henningfield, Vice President of Research, Health Policy, and Abuse Liability at Pinney Associates—the team expressed concern about the omission of key data sources, highlighting areas where the FDA's conclusions were not reliable, valid, or complete. According to the scientists, the FDA analysis also failed to include evidence or input from NIDA or kratom science experts.
"These preeminent scientists have demonstrated that the FDA is a long way away from providing sufficient analysis of kratom to back up its recommendation that this natural botanical be listed as a Schedule I substance," said David Herman, Chairman of the American Kratom Association.
Herman referenced the fact that the full FDA 8-Factor Analysis actually has yet to be made public and that several pages have been omitted in what the FDA claims to be an accidental release. "This whole process raises more questions than answers," said Herman. "However, there is sufficient information in what the FDA has released to reflect that they did not engage in a comprehensive, scientifically-based process, but rather what appears to be an exercise to reinforce its fight against kratom."
In their letter, the scientists call upon the DEA, in conjunction with NIDA, to transparently reexamine the FDA's claim of abuse potential related to kratom and propose regulatory alternatives to its scheduling. Part of that evaluation should include a survey that helps the government better understand how kratom is consumed in the United States.
The letter also calls on the FDA to work with industry groups—such as the American Kratom Association, who have developed Good Manufacturing Practices that lead to safe manufacturing standards that will help keep harmful byproducts out of kratom—to develop regulations that cover the manufacturing of kratom products.
The American Kratom Association adds its voice that the DEA must send this issue back to the FDA to fully re-examine the data, analysis, and conclusions regarding kratom.
ABOUT AKA The American Kratom Association (AKA), a consumer-based non-profit organization, advocates to protect the freedom of consumers to safely consume natural kratom as a part of their personal health and well-being regimen.
AKA represents the nearly 5 million Americans who consume kratom safely each year.
(Reddit post)
LEADING SCIENTISTS RELEASE LETTER CRITICAL OF FDA'S 8-FACTOR ANALYIS
LEADING SCIENTISTS STRONGLY REJECT FDA'S 8-FACTOR ANALYSIS OF KRATOM
CALL UPON THE DEA AND NIDA TO RE-EXAMINE KRATOM ANALYSIS
Washington, D.C.
November 28, 2018
Leading scientists have made public a 33-page letter they have sent to the heads of the U.S. Department of Health and Human Services (HHS), the U.S. Food and Drug Administration (FDA), the Drug Enforcement Administration (DEA), and the National Institute on Drug Abuse (NIDA) expressing strong objections to the methodology and lack of scientific rigor of the FDA's 8-Factor Analysis (8 FA) of kratom.
Among multiple questions raised by the scientists—led by Dr. Jack Henningfield, Vice President of Research, Health Policy, and Abuse Liability at Pinney Associates—the team expressed concern about the omission of key data sources, highlighting areas where the FDA's conclusions were not reliable, valid, or complete. According to the scientists, the FDA analysis also failed to include evidence or input from NIDA or kratom science experts.
"These preeminent scientists have demonstrated that the FDA is a long way away from providing sufficient analysis of kratom to back up its recommendation that this natural botanical be listed as a Schedule I substance," said David Herman, Chairman of the American Kratom Association.
Herman referenced the fact that the full FDA 8-Factor Analysis actually has yet to be made public and that several pages have been omitted in what the FDA claims to be an accidental release. "This whole process raises more questions than answers," said Herman. "However, there is sufficient information in what the FDA has released to reflect that they did not engage in a comprehensive, scientifically-based process, but rather what appears to be an exercise to reinforce its fight against kratom."
In their letter, the scientists call upon the DEA, in conjunction with NIDA, to transparently reexamine the FDA's claim of abuse potential related to kratom and propose regulatory alternatives to its scheduling. Part of that evaluation should include a survey that helps the government better understand how kratom is consumed in the United States.
The letter also calls on the FDA to work with industry groups—such as the American Kratom Association, who have developed Good Manufacturing Practices that lead to safe manufacturing standards that will help keep harmful byproducts out of kratom—to develop regulations that cover the manufacturing of kratom products.
The American Kratom Association adds its voice that the DEA must send this issue back to the FDA to fully re-examine the data, analysis, and conclusions regarding kratom.
ABOUT AKA The American Kratom Association (AKA), a consumer-based non-profit organization, advocates to protect the freedom of consumers to safely consume natural kratom as a part of their personal health and well-being regimen.
AKA represents the nearly 5 million Americans who consume kratom safely each year.
(Reddit post)
-
jabro70
- Kratom Pro (Rank 8)

- Posts: 1091
- Joined: Sat Oct 06, 2018 9:40 am
Re: AKA email 11/28 Scientists Question FDA 8 Factor Analysi
This sounds very encouraging. Hopefully more and more of the nation’s brightest scientists will continue to call out the FDA on their bullshit regarding Kratom.
- BlendsAreMyFriends
- Ultimate Kratomite (Rank 6)

- Posts: 561
- Joined: Tue Apr 03, 2018 7:27 pm
- Location: Downstate New York
Re: AKA email 11/28 Scientists Question FDA 8 Factor Analysi
Thanks bubs, for sharing these here. Information is sometimes time critical so. Staying on top of these things in a timely manner is important.
-
bubbles
- Super Kratomite (Rank 3)
- Posts: 84
- Joined: Fri Apr 06, 2018 12:56 am
Re: AKA email 11/28 Scientists Question FDA 8 Factor Analysi
BlendsAreMyFriends wrote:Thanks bubs, for sharing these here. Information is sometimes time critical so. Staying on top of these things in a timely manner is important.
No problem, Blends! I am happy to make sure information gets out there. I hope your weekend is off to a good start.